Nichols named LLS chief medical officer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Gwen Nichols was named chief medical officer of the Leukemia & Lymphoma Society.

A physician and scientific researcher, Nichols has advanced cures for cancers through a unique combination of clinical, academic and pharmaceutical experience. AS CSO, she will oversee LLS’s scientific research portfolio, patient access services and policy and advocacy initiatives.

Most recently, Nichols was oncology site head of the Roche Translational Clinical Research Center, where she worked to develop new cancer therapies, translating them from the laboratory to clinical trials. Prior to joining Roche in 2007, Nichols was at Columbia University for more than ten years, where she served as the director of the Hematologic Malignancies Program.

Table of Contents

YOU MAY BE INTERESTED IN

Throughout my career as a physician and scientist, I’ve seen ideas once considered impossible become breakthroughs that save lives. They happened because talented scientists had the resources, institutions, and sustained support to pursue ambitious ideas. Most importantly, they knew patients could not afford to wait. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login